Literature DB >> 18985288

The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Hans-Jürgen Möller1.   

Abstract

Europe has a rich tradition in psychopathology and psychiatric classification. This could be helpful developing new classification systems like ICD-11 and DSM-V. Some examples of this are described and further discussed, such as the categorical vs. the syndromatological approach, the relevance of hierarchical rules for the delineation of nosological entities, the antagonistic tradition of unitarian vs. splitting approaches and the relevance of a differentiated psychopathological description. Finally, the conclusion is that a too radical change of the classificatory system, e.g. in the direction of a purely symptomatical/dimensional systematic, or a totally new classification based on modern new biological findings, might be problematic and premature.

Entities:  

Mesh:

Year:  2008        PMID: 18985288     DOI: 10.1007/s00406-008-5004-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  89 in total

1.  Is impaired outcome following a first manic episode due to mood-incongruent psychosis?

Authors:  S M Strakowski; J R Williams; K W Sax; D E Fleck; M P DelBello; M L Bourne
Journal:  J Affect Disord       Date:  2000-12       Impact factor: 4.839

2.  The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.

Authors:  Hans-Jürgen Möller
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

3.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

Authors:  Wiepke Cahn; Hilleke E Hulshoff Pol; Elleke B T E Lems; Neeltje E M van Haren; Hugo G Schnack; Jeroen A van der Linden; Patricia F Schothorst; Herman van Engeland; René S Kahn
Journal:  Arch Gen Psychiatry       Date:  2002-11

4.  The early course of schizophrenia and depression*.

Authors:  Heinz Häfner; Kurt Maurer; Günter Trendler; Wolfram an der Heiden; Martin Schmidt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

5.  A twin study of genetic relationships between psychotic symptoms.

Authors:  Alastair G Cardno; Frühling V Rijsdijk; Pak C Sham; Robin M Murray; Peter McGuffin
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

6.  Neurobiology and the natural history of schizophrenia.

Authors:  Jeffrey A Lieberman
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

Review 7.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Reconsidering the classification of schizophrenia and manic depressive illness--a critical analysis and new conceptual model.

Authors:  Kalina Boteva; Jeffrey Lieberman
Journal:  World J Biol Psychiatry       Date:  2003-04       Impact factor: 4.132

9.  Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.

Authors:  Thomas Frodl; Eva M Meisenzahl; Peter Zill; Thomas Baghai; Dan Rujescu; Gerda Leinsinger; Ronald Bottlender; Cornelius Schüle; Peter Zwanzger; Rolf R Engel; Rainer Rupprecht; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller
Journal:  Arch Gen Psychiatry       Date:  2004-02

10.  The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms.

Authors:  Hans-Jürgen Möller; Ronald Bottlender; Anke Gross; Paul Hoff; Johannes Wittmann; Ulrike Wegner; Anton Strauss
Journal:  Schizophr Res       Date:  2002-07-01       Impact factor: 4.939

View more
  4 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  [In memory of the life and work of Helmut Rennert (1920-1994)].

Authors:  E Kumbier
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

3.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-14       Impact factor: 5.270

4.  Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni; Giuseppe Tusini; Giulia Vannucchi; Hagop S Akiskal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-03-18       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.